Provided by Tiger Fintech (Singapore) Pte. Ltd.

Centessa Pharmaceuticals plc

24.60
+0.45001.86%
Volume:479.44K
Turnover:11.90M
Market Cap:3.30B
PE:-13.75
High:25.30
Open:24.52
Low:24.38
Close:24.15
52wk High:25.30
52wk Low:9.60
Shares:134.07M
Float Shares:84.95M
Volume Ratio:0.94
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7885
EPS(LYR):-2.0595
ROE:-72.92%
ROA:-28.96%
PB:9.56
PE(LYR):-11.94

Loading ...

Mario Alberto Accardi, President of Orexin Program, Reports Disposal of Common Shares of Centessa Pharmaceuticals plc

Reuters
·
Jul 31

Gregory M. Weinhoff, Chief Business Officer, Reports Disposal of Centessa Pharmaceuticals plc Common Shares

Reuters
·
Jul 26

Centessa Pharmaceuticals CEO Saurabh Saha Reports Disposal of Common Shares

Reuters
·
Jul 22

Truist Securities Initiates Coverage on Centessa Pharmaceuticals With Buy Rating

MT Newswires Live
·
Jul 21

Centessa Pharmaceuticals Initiated at Buy by Truist Securities

Dow Jones
·
Jul 21

Iqbal J. Hussain, General Counsel, Reports Disposal of Centessa Pharmaceuticals plc Common Shares

Reuters
·
Jul 18

Nxera Pharma to Receive $4.8 Million in Milestone Payments as Centessa Initiates Clinical Development of ORX142

Reuters
·
Jul 04

Gregory M. Weinhoff, Chief Business Officer, Reports Disposal of Common Shares in Centessa Pharmaceuticals plc

Reuters
·
Jun 26

Iqbal J Hussain, General Counsel, Reports Disposal of Common Shares in Centessa Pharmaceuticals plc

Reuters
·
Jun 26

Mario Alberto Accardi, President of Orexin Program, Reports Disposal of Centessa Pharmaceuticals plc Common Shares

Reuters
·
Jun 26

CEO Saurabh Saha Reports Disposal of Common Shares in Centessa Pharmaceuticals plc

Reuters
·
Jun 21

Centessa Pharmaceuticals plc Conducted Annual General Meeting

Reuters
·
Jun 21

European Equities Traded in the US as American Depositary Receipts Retreat Friday

MT Newswires Live
·
Jun 20

European Equities Traded in the US as American Depositary Receipts Edge Higher Wednesday

MT Newswires Live
·
Jun 18

Centessa Pharmaceuticals Receives FDA Clearance for Phase 1 Clinical Study of ORX142, a Novel Orexin Receptor 2 Agonist

Reuters
·
Jun 16

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT Newswires Live
·
Jun 05

Centessa Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Raphael Deferiere

Reuters
·
Jun 04

Centessa Pharmaceuticals Appoints Raphael Deferiere as Chief Accounting Officer

Reuters
·
May 29

Needham Initiates Centessa Pharmaceuticals ADR at Buy With $35 Price Target

MT Newswires Live
·
May 28

Centessa Pharmaceuticals Initiated at Buy by Needham

Dow Jones
·
May 28